![Tabitha Cunliffe BSc, PhD, FHEA](https://profiles-cardiff.imgix.net/attachments/8122?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Dr Tabitha Cunliffe
BSc, PhD, FHEA
Timau a rolau for Tabitha Cunliffe
Cydymaith Ymchwil
Ysgol y Biowyddorau
Cyhoeddiad
2023
- Mundy, R. M. et al. 2023. Broad sialic acid usage amongst species D human adenovirus. npj Viruses 1 1. (10.1038/s44298-023-00001-5)
- Cunliffe, T. 2023. Establishing new technologies for the development of targeted virotherapies. PhD Thesis , Cardiff University.
2022
- Cunliffe, T. G. , Parker, A. L. and Jaramillo, A. 2022. Pseudotyping bacteriophage P2 tail fibers to extend the host range for biomedical applications. ACS Synthetic Biology 11 (10), pp.3207-3215. (10.1021/acssynbio.1c00629)
- Bates, E. A. et al. 2022. Development of a low seroprevalence, αvβ6 integrin selective virotherapy based on human adenovirus type 10. Molecular Therapy - Oncolytics 25 , pp.43-56. (10.1016/j.omto.2022.03.007)
2020
- Hulin-Curtis, S. et al. 2020. Identification of folate receptor α (FRα) binding oligopeptides and their evaluation for targeted virotherapy applications. Cancer Gene Therapy 27 , pp.785-798. (10.1038/s41417-019-0156-0)
- Cunliffe, T. G. , Bates, E. A. and Parker, A. L. 2020. Hitting the target but missing the point: recent progress towards adenovirus-based precision virotherapies. Cancers 12 (11) 3327. (10.3390/cancers12113327)
Erthyglau
- Mundy, R. M. et al. 2023. Broad sialic acid usage amongst species D human adenovirus. npj Viruses 1 1. (10.1038/s44298-023-00001-5)
- Cunliffe, T. G. , Parker, A. L. and Jaramillo, A. 2022. Pseudotyping bacteriophage P2 tail fibers to extend the host range for biomedical applications. ACS Synthetic Biology 11 (10), pp.3207-3215. (10.1021/acssynbio.1c00629)
- Bates, E. A. et al. 2022. Development of a low seroprevalence, αvβ6 integrin selective virotherapy based on human adenovirus type 10. Molecular Therapy - Oncolytics 25 , pp.43-56. (10.1016/j.omto.2022.03.007)
- Hulin-Curtis, S. et al. 2020. Identification of folate receptor α (FRα) binding oligopeptides and their evaluation for targeted virotherapy applications. Cancer Gene Therapy 27 , pp.785-798. (10.1038/s41417-019-0156-0)
- Cunliffe, T. G. , Bates, E. A. and Parker, A. L. 2020. Hitting the target but missing the point: recent progress towards adenovirus-based precision virotherapies. Cancers 12 (11) 3327. (10.3390/cancers12113327)
Gosodiad
- Cunliffe, T. 2023. Establishing new technologies for the development of targeted virotherapies. PhD Thesis , Cardiff University.